Companies · Other Health Care

Biowave Corp

NORWALK · Other Health Care

Diligence memoA one-page analyst read on Biowave Corp — recommendation, valuation, rhythm, risks.
$2.1M
Total raised · real
2
Rounds
1.3×
Latest step-up
Top 53%
Sector rank · raised
Seed
Latest stage · inferred · Fri Dec 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Biowave Corp looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.74× the median modeled value of Seed Other Health Care companies in 2016–2018 (222 peers) — value vs value, same stage and era.
  • Within the normal band (74% of peer median) for its niche.
Dormant
  • Last raise 7.6 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Biowave Corp is one of 5376 Other Health Care companies tracked from NORWALK. By capital raised it ranks mid-pack (ahead of 48% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2018-12-07
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2016-01-15 Raised $749K (real) Modeled valuation $23M (est)$749K$23MPre-Seed2016Pre-Seed · 2018-12-07 Raised $1.0M (real) Modeled valuation $31M (est)$1.0M$31MPre-Seed2018Seed · 2018-12-07 Raised $1.3M (real) Modeled valuation $33M (est)$1.3M$33MSeed2018+$1.0M+$1.3MCumulative $3.1M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$749K · 2016
Pre-Seed extension$1.0M · 2018
Seed$1.3M · 2018

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$33.0M
Base estimate est.
$1.1M
Conservative case
$258.5M
Upside case
$6.6M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $23.1M · 2016-01-152016Pre-Seed · modeled $30.8M · 2018-12-07Seed · modeled $33.0M · 2018-12-072018
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
6.0 yr
Elapsed time used
7.6 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
17 mo
Avg between rounds
$718K/yr
Capital velocity
10.5 yr
On record since
2016
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.9× of median
This company$2.1M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.8× of median
This company$1.3M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 1.5× above median
This company$33.0M
Sector median$22.1M

Raised more than 48% of sector peers (real $). Modeled value above 60% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #148 of 222.

This companyCohort peer
$10.0M$100.0M$1.0B$1.0M$10.0MCapital raised (log)Eye Academy of America Ltd. · Seed Raised $4.0M · modeled $99.1M (est)Guest House Holdings, LLC · Seed Raised $4.0M · modeled $99.1M (est)Cb Therapeutics Inc. · Seed Raised $4.0M · modeled $99.1M (est)Ruddco Inc. · Seed Raised $4.0M · modeled $99.1M (est)Shift Sciences, LLC · Seed Raised $4.0M · modeled $98.6M (est)BHCP OK4 HH/H Investors, LLC · Seed Raised $4.0M · modeled $97.9M (est)ReNovo, Inc. · Seed Raised $4.0M · modeled $97.9M (est)CCRC of Lenexa, LLC · Seed Raised $3.9M · modeled $97.6M (est)Nocira, Llc · Seed Raised $3.9M · modeled $96.7M (est)PureFlowCath, LLC · Seed Raised $3.8M · modeled $94.6M (est)Prevent Biometrics, Inc. · Seed Raised $4.2M · modeled $94.2M (est)Medal, Inc. · Seed Raised $3.8M · modeled $93.6M (est)Biowave Corp (this company) Raised $2.1M · modeled $33.0M (est)Biowave Corp
CompanyStageRaised · realValue · estvs peer med.
Eye Academy of America Ltd.Seed$4.0M$99.1M2.23×
Guest House Holdings, LLCSeed$4.0M$99.1M2.23×
Cb Therapeutics Inc.Seed$4.0M$99.1M2.23×
Ruddco Inc.Seed$4.0M$99.1M2.23×
Shift Sciences, LLCSeed$4.0M$98.6M2.22×
BHCP OK4 HH/H Investors, LLCSeed$4.0M$97.9M2.21×
ReNovo, Inc.Seed$4.0M$97.9M2.21×
CCRC of Lenexa, LLCSeed$3.9M$97.6M2.20×
Nocira, LlcSeed$3.9M$96.7M2.18×
PureFlowCath, LLCSeed$3.8M$94.6M2.13×
Prevent Biometrics, Inc.Seed$4.2M$94.2M2.12×
Medal, Inc.Seed$3.8M$93.6M2.11×
Biowave Corp this companySeed$2.1M$33.0M0.74×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$749K2016-01-15$4.2M$23.1M85%
Pre-Seed$1.0M2018-12-07$5.6M$30.8M90%
Seed$1.3M2018-12-07$6.6M$33.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$749K2016-01-15
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Pre-Seed$1.0M2018-12-07
    • Raised again after 35 mo — slower than the ~14 mo sector norm.
    • Round 1.3× larger than the prior — scaling up.
    • 1 investor on this round.
  3. Seed$1.3M2018-12-07
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× larger than the prior — scaling up.
    • 3 investors on this round.
Intelligence
2020 ~Q2
Modeled next raise · ~17mo cadence
$1.8M
Modeled next size est.range $1.3M$2.8M
1.3×
Last step-up
$718K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Bruce Lev6 other2016-01
Lance Lundberg2 other2016-01
Robert Adler2 other2016-01
Bradford Siff2016-01
David Kratovil2016-01
L. Charles (Duke) Meythaler2016-01
Registry & provenance

Biowave Corp is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1144161
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Better Pt Inc.Other Health CareSeed$5.0M$10.5Mnetwork1 shared operator · same sector · same stage
Coagulation Sciences LLCOther Health CareSeed$2.1M$31.6Msame sector · same stage
SureTest, Inc.Other Health CareSeed$2.1M$35.5Msame sector · same stage
Camino InterWell Class B, LLCOther Health CareSeed$2.0M$35.1Msame sector · same stage
Good Type, Inc.Other Health CareSeed$2.0M$28.0Msame sector · same stage
SonoVascular, Inc.Other Health CareSeed$2.2M$28.8Msame sector · same stage
Acesohouse, LLCOther Health CareSeed$2.2M$30.1Msame sector · same stage
Freedom Health Holdings, LLCOther Health CareSeed$2.3M$37.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
CarbonWave, Inc.Other Health CareSeed$13.1M91%
Spine Wave, IncOther Health CareSeries B$117.4M89%
Waveguide CorpOther Health CareSeries B$15.1M88%
BioCeryx Inc.Other Health CareSeries A$100.9M88%
Biolux Research Holdings, Inc.Other Health CareSeries A$256.3M87%
BioMatrix Holdings, L.L.C.Other Health CareSeries C$1.8B87%
BioMedx Group, Inc.Other Health CarePre-Seed$14.0M86%
Biocardia Lifesciences, Inc.Other Health CareSeries A$88.3M86%
Frequently asked
How much funding has Biowave Corp raised?
Biowave Corp has raised approximately $2.1M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Biowave Corp's estimated valuation?
Provath's modeled valuation for Biowave Corp is approximately $33.0M (modeled range $1.1M–$258.5M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Biowave Corp at?
Biowave Corp's latest modeled financing stage is Seed. Its most recent recorded round closed around Fri Dec 07.
What does Biowave Corp do and where is it based?
Biowave Corp operates in the Other Health Care sector, based in NORWALK.
Explore related

See where Biowave Corp sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Biowave Corp, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.